C6ORF150 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.939800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.107000E-01
Normal-vs-Stage2
6.958800E-01
Normal-vs-Stage3
5.121200E-01
Normal-vs-Stage4
1.401650E-01
Stage1-vs-Stage2
2.190000E-01
Stage1-vs-Stage3
8.230600E-01
Stage1-vs-Stage4
1.573720E-02
Stage2-vs-Stage3
2.431200E-01
Stage2-vs-Stage4
1.082130E-02
Stage3-vs-Stage4
4.486200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.790000E-01
Normal-vs-AfricanAmerican
9.162000E-01
Normal-vs-Asian
9.356200E-01
Caucasian-vs-AfricanAmerican
3.446200E-01
Caucasian-vs-Asian
5.132600E-01
AfricanAmerican-vs-Asian
7.158400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.973600E-01
Normal-vs-Female
7.854000E-01
Male-vs-Female
7.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.892000E-01
Normal-vs-Age(41-60Yrs)
6.928000E-01
Normal-vs-Age(61-80Yrs)
8.507000E-01
Normal-vs-Age(81-100Yrs)
8.147200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.092000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.045000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.119200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.273400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.456800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.683800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.290800E-01
Normal-vs-Daily Drinker
9.304000E-01
Normal-vs-Weekly Drinker
8.434600E-01
Normal-vs-Occasional Drinker
6.462400E-01
Normal-vs-Social Drinker
9.629800E-01
Non Drinker-vs-Daily Drinker
5.219200E-01
Non Drinker-vs-Weekly Drinker
9.581200E-01
Non Drinker-vs-Occasional Drinker
4.636400E-01
Non Drinker-vs-Social Drinker
6.019400E-01
Daily Drinker-vs-Weekly Drinker
6.217200E-01
Daily Drinker-vs-Occasional Drinker
2.416200E-01
Daily Drinker-vs-Social Drinker
9.066400E-01
Weekly Drinker-vs-Occasional Drinker
4.687600E-01
Weekly Drinker-vs-Social Drinker
6.499400E-01
Occasional Drinker-vs-Social Drinker
2.710200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.555000E-01
Normal-vs-Grade 2
3.173400E-01
Normal-vs-Grade 3
2.346200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.199000E-04
Grade 1-vs-Grade 3
1.039430E-03
Grade 1-vs-Grade 4
8.555000E-01
Grade 2-vs-Grade 3
7.521200E-01
Grade 2-vs-Grade 4
3.173400E-01
Grade 3-vs-Grade 4
2.346200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.195600E-01
Normal-vs-NonDiabetic
8.553600E-01
Diabetic-vs-NonDiabetic
9.975000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.488800E-01
Normal-vs-NoPancreatitis
8.188600E-01
Pancreatitis-vs-NoPancreatitis
9.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.070200E-01
Normal-vs-N1
6.699000E-01
N0-vs-N1
3.073800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.246400E-01
Normal-vs-TP53-NonMutant
8.060800E-01
TP53-Mutant-vs-TP53-NonMutant
2.060900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
